Hisamitsu Pharmaceutical CEOs: 2 Presidents Since 1981

Revenue and CEOs2 CEOs
Hisamitsu Pharmaceutical
CEOs and long-term results
FY2025
Consolidated
Revenue
¥156.0 billion
Net margin
14%
Hirotaka NakatomiKazuhide Nakatomi
Revenue¥3.4 billionRevenue¥9.0 billionRevenue¥16.0 billionRevenue¥156.8 billionRevenue¥156.0 billionNet margin8.8%Net margin3.3%Net margin3.8%Net margin12%Net margin14%1960/21965/21970/21975/21980/21985/21990/21995/22000/22005/22010/22015/22020/22025/22030/2
Revenue¥3.4 billionRevenue¥16.0 billionRevenue¥156.0 billionNet margin8.8%Net margin3.8%Net margin14%1959/21965/21975/21985/21995/22005/22015/22025/2
Tenure timeline
198019902000201020202030
Hirotaka NakatomiKazuhide Nakatomi
Presidents2